UK markets close in 7 hours 29 minutes

Gland Pharma Limited (GLAND.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,797.00+11.80 (+0.66%)
As of 01:31PM IST. Market open.

Gland Pharma Limited

Plot No. 11 & 84, TSIIC Phase: IV
Pashamylaram (V) Patancheru (M) Sangareddy District
Hyderabad 502307
India
91 84 5569 9999
https://www.glandpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers - General
Full-time employees4,209

Key executives

NameTitlePayExercisedYear born
Mr. Srinivas SaduMD, CEO & Executive Chairman123.58MN/A1969
Mr. Ravi Shekhar MitraChief Financial Officer15.15MN/A1977
Mr. Sampath Kumar PallerlamudiCompany Secretary & Vice-President of Compliance & CSR5.11MN/A1981
Mr. Satnam Singh LoombaChief Operating OfficerN/AN/A1968
Mr. Ankit GuptaHead of Investments, Strategy & Investor RelationsN/AN/AN/A
Mr. Surinder KoulHead of Domestic MarketingN/AN/AN/A
Ms. Shilpi SahayDeputy General Manager of Human ResourcesN/AN/A1981
Dr. C. S. VenkatesanSenior Vice President of R&DN/AN/A1971
Dr. Surapanini SrideviSenior Vice President of R&DN/AN/A1968
Mr. K Raghuramachandra RaoHead of QualityN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Gland Pharma Limited engages in manufacturing and sale of injectable formulation in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical API products including synthesis of complex drug molecules, such as LMWH, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro intestinal, gynecological, hormones, neuro/Cns, ophthal/ontological, and other areas, as well as pain and analgesics, respirator, and vitamins, minerals and nutrients; and offers contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Corporate governance

Gland Pharma Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.